Fundamental dimension Equity attribute | SKILPeer $5.27▼-6.89% Cap $47.96MP/E -0.3x QuantScore33/100 | CHGGLeader $0.7022▲+4.79% Cap $77.96MP/E -1.4x QuantScore36/100 | GNSPeer $0.1314▼-2.30% Cap $25.22MP/E -0.6x QuantScore21/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
25/100 |
35/100 |
24/100 |
Valuation Multiples, PEG & DCF upside | 59/100 | 33/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 34/100 | 28/100 | 25/100 |
Growth Revenue / earnings growth & margins | 21/100 | 35/100 | 37/100 |
Sentiment Analyst ratings, targets & revisions | 25/100 | 50/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -0.3x | -1.4x | -0.6x |
Forward P/E (next FY) | 1.3x | -5.4x | -1.6x |
EV / EBITDA (TTM) | 8.8x | 2.0x | -2.7x |
Price / Sales | 0.1x | 0.3x | 3.3x |
Price / Free Cash Flow | 3.6x | -101.1x | -33.0x |
PEG ratio | 0.01 | -0.02 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 4 / 9 | 2 / 9 |
Altman Z-Score | -2.72 (Distress) | -4.67 (Distress) | -1.41 (Distress) |
Total debt / equity | -6.15 | 0.43 | 0.13 |
Quick ratio | 0.9x | 1.2x | 0.7x |
Interest coverage | -0.2x | -28.0x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -3.5% | -39.0% | +6.0% |
Net income growth YoY | -14.7% | +87.6% | -122.1% |
Gross margin (TTM) | 77.8% | 58.7% | 51.5% |
Operating margin (FY) | -7.6% | -16.8% | -323.2% |
FCF margin (FY) | 4.5% | -3.4% | -181.6% |
5. Trailing price performancePrice change over period |
1M return | -11.4% | -3.2% | -16.5% |
3M return | -17.0% | -27.0% | -21.3% |
6M return | -18.0% | -31.8% | -59.6% |
Year to date | -43.3% | -24.5% | -77.1% |
1Y return | -63.6% | -49.5% | -84.2% |
3Y return | -70.6% | -91.5% | -98.4% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-125.49 -2481.2% premium | $-8.86 -1362.2% premium | $-0.4823 -467.0% premium |
Wall Street consensus target | $2.30 -56.4% · range $2.30–$2.30 | $30.42 +4232.1% · range $1.50–$110.00 | — — |
Consensus stance | 60% Buy40% Hold0% Sell | 27% Buy55% Hold18% Sell | — |